← FDA DRUG APPROVALS

FDA ANDA · ANDA075953

TERCONAZOLE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA075953
TYPE
ANDA
ORIGINAL APPROVAL
2004-04-06
LATEST ACTION
2015-08-25
ROUTE
VAGINAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

TERCONAZOLEPrescription
TERCONAZOLE 0.8% · CREAM · VAGINAL

Approval history

2015-08-25Labeling · Supplement 11 · standardAP
2015-08-25Labeling · Supplement 12 · standardAP
2004-04-06OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →